Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Oral Oncol. 2013 Nov 21;50(2):104–112. doi: 10.1016/j.oraloncology.2013.10.014

Figure 3.

Figure 3

Pharmacological inhibition of Met reduces cell motility. Cell scatter responses of JHU-SCC-012 (A) or JHU-SCC-019 (B) cells treated with (+) or without (−) HGF and/or SU11274 as indicated. Representative images from triplicate experiments are shown. Wound healing assays were performed using JHU-SCC-012 (C) or JHU-SCC-019 (D) cells as indicated and are reported as the area remaining at each time point (18 or 25 h) following HGF treatment (0 h) (Anova, ** p < 0.01) of triplicate experiments.